Cargando…

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma

The aim of this study was to investigate the prognostic and diagnostic value of genes with promoter methylation in hepatocellular carcinoma (HCC) patients. On the basis of The Cancer Genome Atlas data, we identified genes with differentially methylated promoters in HCC tissues and adjacent non-tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Dani, Cen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428754/ https://www.ncbi.nlm.nih.gov/pubmed/28507442 http://dx.doi.org/10.2147/OTT.S128058

Ejemplares similares

Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival
por: Guan, Renguo, et al.
Publicado: (2020)

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma
por: Yu, Qiwen, et al.
Publicado: (2019)

An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013)

A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
por: Yang, Yuan, et al.
Publicado: (2017)

Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
por: DONG, YOUHONG, et al.
Publicado: (2014)

Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma
por: Cai, Changzhou, et al.
Publicado: (2019)

Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma
por: Huang, Peng, et al.
Publicado: (2021)

A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma
por: Dong, Yuting, et al.
Publicado: (2022)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma
por: Yu, Dianke, et al.
Publicado: (2015)

Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
por: Dong, Yuting, et al.
Publicado: (2023)

Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma
por: Sang, Liang, et al.
Publicado: (2018)

Detection of Aberrant p16(INK4A) Methylation in Sera of Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Chu, Hyung Jun, et al.
Publicado: (2004)

Aberrant FHIT transcripts in hepatocellular carcinomas.
por: Chen, Y. J., et al.
Publicado: (1998)

Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
por: Tian, Ying, et al.
Publicado: (2020)

Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis
por: Zhang, Guizhi, et al.
Publicado: (2022)

Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis
por: Cai, Fucheng, et al.
Publicado: (2016)

APC promoter methylation and protein expression in hepatocellular carcinoma
por: Csepregi, Antal, et al.
Publicado: (2007)

Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors
por: Lambert, Marie-Pierre, et al.
Publicado: (2015)

Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma
por: Wu, Jin-Cai, et al.
Publicado: (2014)

Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma
por: Li, Bing, et al.
Publicado: (2014)

Aberrant methylation of EYA4 promotes epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
por: Luo, Mei, et al.
Publicado: (2018)

Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling
por: Yang, Ju Dong, et al.
Publicado: (2011)

Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
por: Gonzalo, Victoria, et al.
Publicado: (2010)

Promoter Methylation of SFRP3 Is Frequent in Hepatocellular Carcinoma
por: Lin, Ya-Wen, et al.
Publicado: (2014)

Promoter Methylation of E-cadherin in Hepatocellular Carcinomas and Dysplastic Nodules
por: Kwon, Ghee Young, et al.
Publicado: (2005)

Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival
por: Zhang, Miao, et al.
Publicado: (2019)

Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2020)

Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization
por: Aly, Magdy S., et al.
Publicado: (2010)

Aberrant regulation of Wnt signaling in hepatocellular carcinoma
por: Liu, Li-Juan, et al.
Publicado: (2016)

Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients
por: Wu, Jiaoxiang, et al.
Publicado: (2023)

Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017)

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2014)

Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer
por: Sahnane, Nora, et al.
Publicado: (2015)

Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma
por: El-Mougy, Fatma A., et al.
Publicado: (2014)

High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes
por: Abe, Masanobu, et al.
Publicado: (2016)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu, Yituo, et al.
Publicado: (2021)

Osteoponin Promoter Controlled by DNA Methylation: Aberrant Methylation in Cloned Porcine Genome
por: Shen, Chih-Jie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3rqimp2sbr6ag1mdcmo8eoj6l5